Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires

Table 2 Socio-demographic characteristics of the study participants and association with adherence to nucleos(t)ide analogues (n = 80) n (%)

Characteristics	Patients	Optimal adherence	P value
Sex			0.28
Male	52 (65)	29 (61.7)
Female	28 (35)	20 (71.4)
Age (yr)			0.27
18-29	6 (7.5)	2 (33.3)
30-39	9 (11.3)	4 (50.0)
40-49	19 (23.8)	14 (77.8)
50-59	27 (33.8)	16 (66.7)
≥ 60	19 (23.8)	13 (77.2)
Country of birth			0.39
Korea	9 (11.5)	4 (57.1)
China	28 (35.9)	16 (59.3)
Hong Kong	11 (14.1)	9 (81.8)
Malaysia	6 (7.7)	3 (60.0)
Singapore	1 (1.3)	1 (100.0)
Vietnam	9 (11.5)	3 (37.5)
Australia	3 (3.8)	3 (100.0)
Indonesia	3 (3.8)	3 (100.0)
Tonga	1 (1.3)	1 (100.0)
India	1 (1.3)	1 (100.0)
Fiji	1 (1.3)	1 (100.0)
Cyprus	1 (1.3)	1 (100.0)
Cambodia	2 (2.5)	2 (100.0)
Taiwan	1 (1.3)	0 (0.00)
Ethnicity			0.60
Anglo-Celt	1 (1.3)	1 (100.0)
Middle East	1 (1.3)	1 (100.0)
Asian	75 (93.8)	44 (63.8)
Pacific	2 (2.5)	2 (100.0)
Other	1 (1.3)	1 (100.0)
Highest level of education completed			0.08
Completed high school	28 (35.4)	22 (81.5)
Completed college/university	46 (58.2)	23 (56.1)
Did not complete high school	2 (2.5)	3 (75.0)
Did not complete college/ university	1 (1.3)	0 (0.00)